Table 5.
Effect of NM on cancer cell proliferation
| Cancer cell line | Percent Inhibition of cell growth at NM 1,000 μg/mL |
|---|---|
| Breast (MBA-MB-231) | 50% |
| Breast (MCF-7 estrogen sensitive) + estradiol | 25% |
| Osteosarcoma (MNNG) | 10% |
| Cervical cancer HeLa | 37% |
| Lung carcinoma (A-549) | 20% |
| Pancreas (MIA PACA-2) | 38% |
| Prostate (LNCaP) | 80% |
| Osteosarcoma (U2OS) | 60% |
| Rhabdomyosarcoma | 20% |
| Prostate (DU-145) | 47% |
| Hepatocellular carcinoma SK-Hep-1 | 33% |
| Fibrosarcoma HT1080 | 37% |
| Cervical Cancer (DoTc2451) | 45% |
| Prostate PC-3 | 40% |
| Synovial carcinoma | 28% |
| Melanoma A2058 | 64% |
| Glioma A-172 | 50% |
| Liposarcoma SW-872 | 61% |